CompletedPhase 4NCT01853696
Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty
Studying Corneal dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cornea Research Foundation of America
- Principal Investigator
- Francis W Price, Jr., MDPrice Vision Group
- Intervention
- loteprednol etabonate(drug)
- Enrollment
- 167 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2015
Study locations (1)
- Price Vision Group, Indianapolis, Indiana, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01853696 on ClinicalTrials.govOther trials for Corneal dystrophy
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07217249Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 YearsCase Western Reserve University
- RECRUITINGNANCT07373821Influence of Supine Positioning on the Outcomes After Descemet Membrane Endothelial Keratoplasty (DMEK)University Hospital Heidelberg
- RECRUITINGPHASE2NCT07024693DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal DystrophyDesign Therapeutics, Inc.
- RECRUITINGNANCT06844123Microsurgical Robot-assisted Corneal TransplantCHU de Reims
- RECRUITINGNANCT06425666Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal DystrophyUniversity of Cologne
- RECRUITINGNCT06966167Comparison of Outcomes Between Femtosecond Laser-Assisted and Conventional Phacoemulsification in Fuchs Endothelial Corneal Dystrophy Patients With CataractsEye & ENT Hospital of Fudan University
- RECRUITINGNCT06859411Prognosis of Posterior Lamellar Keratoplasty, an Observational Cohort StudyCentre Hospitalier Régional Metz-Thionville
- RECRUITINGPHASE3NCT05275972Descemet Endothelial Thickness Comparison Trial IIStanford University